142 related articles for article (PubMed ID: 27721685)
1. A CASE REPORT OF SUSPECTED ANGIOEDEMA IN A CHILD AFTER ADMINISTRATION OF MEBENDAZOLE, COTRIMOXAZOLE AND LEAF EXTRACTS.
Ashubu OF; Ademola AD; Asinobi AO
Ann Ib Postgrad Med; 2016 Jun; 14(1):41-43. PubMed ID: 27721685
[TBL] [Abstract][Full Text] [Related]
2. Hypersensitivity to Ibuprofen: Real-Life Experience in Children with History of Suspected Immediate Reactions.
Sipahi Cimen S; Yucel E; Suleyman A; Hizli Demirkale Z; Ozceker D; Sayili U; Guler N; Tamay Z
Int Arch Allergy Immunol; 2023; 184(1):33-42. PubMed ID: 36282068
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and Updated Classification of Acute Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): NSAID-Exacerbated or -Induced Food Allergy.
Romano A; Gaeta F; Caruso C; Fiocchi A; Valluzzi RL
J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1843-1853.e1. PubMed ID: 36997117
[TBL] [Abstract][Full Text] [Related]
5. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
[TBL] [Abstract][Full Text] [Related]
6. Indirect and Direct 65+ Patient Reporting of Non-Steroidal Anti-Inflammatory Drug-Induced Adverse Drug Reactions as a Source of Information on Polypharmacy and Polypharmacy-Related Risk.
Sienkiewicz K; Burzyńska M; Rydlewska-Liszkowska I; Sienkiewicz J; Gaszyńska E
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763704
[No Abstract] [Full Text] [Related]
7. Drug-induced angioedema without urticaria: prevalence and clinical features.
Leeyaphan C; Kulthanan K; Jongjarearnprasert K; Dhana N
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):685-91. PubMed ID: 19925599
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous reactions to non-steroidal anti-inflammatory drugs.
Kasemsarn P; Kulthanan K; Tuchinda P; Dhana N; Jongjarearnprasert K
J Drugs Dermatol; 2011 Oct; 10(10):1160-7. PubMed ID: 21968666
[TBL] [Abstract][Full Text] [Related]
9. Safety of direct oral provocation test to delabel reported mild beta-lactam allergy in infants.
Cunha F; Cunha I; Gomes E
Allergol Immunopathol (Madr); 2024; 52(2):10-15. PubMed ID: 38459885
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled trial.
Speich B; Ali SM; Ame SM; Bogoch II; Alles R; Huwyler J; Albonico M; Hattendorf J; Utzinger J; Keiser J
Lancet Infect Dis; 2015 Mar; 15(3):277-84. PubMed ID: 25589326
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of anaemia in HIV-infected children at the University of Abuja Teaching Hospital, Gwagwalada.
Okechukwu AA; Gambo D; Okechukwu IO
Niger J Med; 2010; 19(1):50-7. PubMed ID: 20232757
[TBL] [Abstract][Full Text] [Related]
12. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.
Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
Am J Clin Dermatol; 2002; 3(9):599-607. PubMed ID: 12444802
[TBL] [Abstract][Full Text] [Related]
13. Practical Approach to Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Children.
Podlecka D; Socha-Banasiak A; Jerzynska J; Nodzykowska J; Brzozowska A
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765044
[TBL] [Abstract][Full Text] [Related]
14. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.
Chaudhry T; Hissaria P; Wiese M; Heddle R; Kette F; Smith WB
Intern Med J; 2012 Jun; 42(6):665-71. PubMed ID: 21981353
[TBL] [Abstract][Full Text] [Related]
15. Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions.
Zisa G; Riccobono F; Bommarito L; D'Antonio C; Calamari AM; Poppa M; Moschella MA; Di Pietrantonj C; Galimberti M
Allergy Asthma Proc; 2012; 33(5):421-6. PubMed ID: 23026184
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood.
Sánchez-Borges M; Capriles-Behrens E; Caballero-Fonseca F
Pediatr Allergy Immunol; 2004 Aug; 15(4):376-80. PubMed ID: 15305949
[TBL] [Abstract][Full Text] [Related]
17. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study.
Lima EDC; Matos GC; Vieira JML; Gonçalves ICDCR; Cabral LM; Turner MA
J Pediatr (Rio J); 2019; 95(6):682-688. PubMed ID: 30030984
[TBL] [Abstract][Full Text] [Related]
18. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
[TBL] [Abstract][Full Text] [Related]
19. Clinical study of cutaneous drug eruptions in 200 patients.
Patel RM; Marfatia YS
Indian J Dermatol Venereol Leprol; 2008; 74(4):430. PubMed ID: 18810845
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]